GlassScriptPhysician profile
Brian Burkardt
NPI 1699721274
$3,368.31
in general payments reported to CMS, 2019-2025
10 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $207 · 2021: $237 · 2022: $633 · 2023: $846 · 2024: $555 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $1,548.36 | 2023-2025 | Acumed, Osteomed, Acumed |
| Osteomed LLC | $1,220.20 | 2019-2022 | |
| Stryker Corporation | $170.07 | 2021-2025 | Actishield, Prostep Mica |
| Treace Medical Concepts, INC. | $117.66 | 2025 | |
| Paragon 28, INC. | $106.95 | 2019-2022 | |
| Cardiovascular Systems INC. | $77.94 | 2019 | |
| Pinnacle, INC | $75.42 | 2022-2025 | |
| Solventum Corporation | $21.01 | 2025 | Promogran Prisma, 3m Cavilon, Activ.A.C. |
| Smith+Nephew, INC. | $19.80 | 2021 | |
| Arthrosurface Incorporated | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Burkardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.